Cholecystectomy among patients with irritable bowel syndrome: a systematic review and meta-analysis
Open Access
- 6 November 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Gastroenterology
- Vol. 5, 1977232
Abstract
Background: Irritable bowel syndrome (IBS) and gallbladder disease share overlapping symptoms that may contribute to diagnostic uncertainty and unnecessary cholecystectomy. This systematic review and meta-analysis evaluated whether patients with IBS are more likely to undergo cholecystectomy than those without IBS. Methods: A systematic search of PubMed, Embase, Web of Science, and Google Scholar was conducted through June 3, 2026. Observational studies comparing cholecystectomy among adults with and without IBS were included. Random-effects meta-analysis was performed to calculate pooled odds ratios (ORs) with 95% confidence intervals (CIs). Subgroup analyses, sensitivity analyses, influence diagnostics, meta-regression, publication bias assessment, and risk-of-bias evaluation were conducted. Results: Ten studies met the inclusion criteria for the systematic review, and nine studies comprising 181,848 participants and 6,249 cholecystectomy events were included in the meta-analysis. Patients with IBS had significantly higher odds of undergoing cholecystectomy than controls (OR = 2.57, 95% CI 1.36–4.85; p = 0.009). Between-study heterogeneity was substantial (I 2 = 98.1%), but the association remained robust across leave-one-out sensitivity analyses. Subgroup analyses and meta-regression demonstrated that study design, geographic region, IBS diagnostic criteria, study quality, and sample size did not significantly influence the pooled effect estimate. No evidence of publication bias was detected, and the included studies were generally of good methodological quality. Conclusions: Patients with IBS have significantly higher odds of undergoing cholecystectomy than individuals without IBS. These findings support careful evaluation of biliary symptoms in patients with IBS to improve diagnostic accuracy, optimize patient selection for surgery, and reduce unnecessary cholecystectomy. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261412571 , identifier CRD420261412571.Keywords
This publication has 53 references indexed in Scilit:
- Restrictive Strategy vs Usual Care for Cholecystectomy in Patients With Abdominal Pain and GallstonesJAMA Surgery, 2024
- Healthcare Utilization Patterns: Irritable Bowel Syndrome, Inflammatory Bowel Disease, and Gastroesophageal Reflux DiseaseDigestive Diseases and Sciences, 2024
- Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trialsSurgery, 2023
- The Socioeconomic Impact of Irritable Bowel Syndrome: An Analysis of Direct and Indirect Health Care CostsClinical Gastroenterology and Hepatology, 2023
- Health care utilization of individuals with Rome IV irritable bowel syndrome in the general populationUnited European Gastroenterology Journal, 2021
- Restrictive strategy versus usual care for cholecystectomy in patients with gallstones and abdominal pain (SECURE): a multicentre, randomised, parallel-arm, non-inferiority trialThe Lancet, 2019
- Sphincter of Oddi dysfunction: the never-ending story has come to a conclusionGastrointestinal Endoscopy, 2018
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Gallstones, cholecystectomy and irritable bowel syndrome (IBS)Digestive and Liver Disease, 2008